The Magazine for Sleep Professionals
Saturday, August 22, 2026
Onera Health announces that the quality management system of its legal manufacturing subsidiary, Onera B.V., has been certified to meet the requirements of MDR (EU) 2017/745 regulation (Annex IX, chapter I and III).. The Onera STS 2 system, which will be marketed as part of the Onera hPSG® solution, falls within […]
The National Sleep Foundation (NSF) announced the first confirmed speakers for its 2026 NSF Drowsy Driving Forum, bringing together an unprecedented group of national leaders to address one of the nation’s most persistent – and preventable – public health and roadway safety challenges. The Forum’s Leadership Panel will feature: Jonathan […]
Iranian National residing in Coos Bay pleaded guilty today to conspiracy to commit healthcare fraud. Mehrdad Gerami, Age 67, pleaded guilty to conspiracy to commit healthcare fraud. According to court documents, from 2021 to the present, Gerami was the owner and operator of Coastal Diagnostic Testing Group (CDTG). CDTG operates […]
Cathay Capital announced the launch of ReDream Brands, a new consumer sleep health platform dedicated to helping millions of people achieve better sleep and healthier lives. The platform brings together four of the industry’s most recognized direct-to-consumer brands: cpap.com, The CPAP Shop, Lofta and sleeping.com, creating a leading platform for […]
CND Life Sciences announced the completion of growth financing led by S-Curve Partners, an operator-led healthcare investment firm focused on founder-inspired healthcare technology and diagnostics businesses. S-Curve was joined by current CND investors and shareholders, reflecting continued confidence in the Company’s commercial trajectory, expanding clinical adoption, and long-term strategic positioning. […]
TAP Sleep Care highlighted clinical evidence on Combination Therapy for CPAP-Resistant Obstructive Sleep Apnea from Martin A. Denbar, DDS, DABDSM, Diplomate of the American Board of Dental Sleep Medicine and Adjunct Assistant Professor in the Department of Internal Medicine at Texas A&M School of Medicine (Texas Dental Sleep Services). The […]
Takeda announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. […]
Nightmares are among the most agonizing symptoms of post-traumatic stress disorder (PTSD) – a condition that can develop after exposure to severe traumatic experiences, such as disasters, serious accidents, acts of violence, or wartime experiences. Individuals affected relive the events intensely at night, as if they were real, time and […]
A novel AI model can use information collected during routine sleep studies to identify patients’ long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research team, the model uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline and death. The […]
The U.S. Food and Drug Administration today approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. Orzeyful is the first medicine approved for narcolepsy type 1 as a complete disorder — addressing the full range of symptoms that define the condition — and the first to […]
